{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:51:25Z","timestamp":1788522685455,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81372069"],"award-info":[{"award-number":["81372069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601693"],"award-info":[{"award-number":["81601693"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703924"],"award-info":[{"award-number":["81703924"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Hist"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10735-018-9778-z","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T09:52:44Z","timestamp":1526896364000},"page":"377-387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["miR-155 inhibits the formation of hypertrophic scar fibroblasts by targeting HIF-1\u03b1 via PI3K\/AKT pathway"],"prefix":"10.1007","volume":"49","author":[{"given":"Xue","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuekang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"issue":"Suppl 1","key":"9778_CR1","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1111\/j.1524-475X.2007.00219.x","volume":"15","author":"A Armour","year":"2007","unstructured":"Armour A, Scott PG, Tredget EE (2007) Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen 15(Suppl 1):S6\u2013S17. \n                    https:\/\/doi.org\/10.1111\/j.1524-475X.2007.00219.x","journal-title":"Wound Repair Regen"},{"key":"9778_CR2","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.biocel.2009.09.016","volume":"42","author":"K Breving","year":"2010","unstructured":"Breving K, Esquela-Kerscher A (2010) The complexities of microRNA regulation: mirandering around the rules. Int J Biochem Cell Biol 42:1316\u20131329. \n                    https:\/\/doi.org\/10.1016\/j.biocel.2009.09.016","journal-title":"Int J Biochem Cell Biol"},{"key":"9778_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2174\/138161209787315873","volume":"15","author":"RC Castellino","year":"2009","unstructured":"Castellino RC, Muh CR, Durden DL (2009) PI-3 kinase-PTEN signaling node: an intercept point for the control of angiogenesis. Curr Pharm Des 15:380\u2013388","journal-title":"Curr Pharm Des"},{"key":"9778_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/jcp.24492","volume":"229","author":"Z Chen","year":"2014","unstructured":"Chen Z, Ma T, Huang C, Hu T, Li J (2014) The pivotal role of microRNA-155 in the control of cancer. J Cell Physiol 229:545\u2013550. \n                    https:\/\/doi.org\/10.1002\/jcp.24492","journal-title":"J Cell Physiol"},{"key":"9778_CR5","doi-asserted-by":"publisher","first-page":"e81773","DOI":"10.1371\/journal.pone.0081773","volume":"8","author":"YH Choi","year":"2013","unstructured":"Choi YH, Jin GY, Li LC, Yan GH (2013) Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K\/Akt\/mTOR\/HIF-1 alpha\/VEGF pathway. PLoS ONE 8:e81773. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0081773","journal-title":"PLoS ONE"},{"key":"9778_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-016-1054-6","volume":"18","author":"RB Christmann","year":"2016","unstructured":"Christmann RB et al (2016) miR-155 in the progression of lung fibrosis in systemic sclerosis. Arthritis Res Ther 18:155. \n                    https:\/\/doi.org\/10.1186\/s13075-016-1054-6","journal-title":"Arthritis Res Ther"},{"key":"9778_CR7","doi-asserted-by":"publisher","first-page":"e0129251","DOI":"10.1371\/journal.pone.0129251","volume":"10","author":"T Csak","year":"2015","unstructured":"Csak T, Bala S, Lippai D, Kodys K, Catalano D, Iracheta-Vellve A, Szabo G (2015) MicroRNA-155 deficiency attenuates liver steatosis and fibrosis without reducing inflammation in a mouse model of steatohepatitis. PLoS ONE 10:e0129251. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0129251","journal-title":"PLoS ONE"},{"key":"9778_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/PRS.0000000000001699","volume":"136","author":"D Duscher","year":"2015","unstructured":"Duscher D et al (2015) Fibroblast-specific deletion of hypoxia inducible factor-1 critically impairs murine cutaneous neovascularization and wound healing. Plast Reconstr Surg 136:1004\u20131013. \n                    https:\/\/doi.org\/10.1097\/PRS.0000000000001699","journal-title":"Plast Reconstr Surg"},{"key":"9778_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1096\/fj.04-2175com","volume":"19","author":"J Fang","year":"2005","unstructured":"Fang J, Xia C, Cao Z, Zheng JZ, Reed E, Jiang BH (2005) Apigenin inhibits VEGF and HIF-1 expression via PI3K\/AKT\/p70S6K1 and HDM2\/p53 pathways. FASEB J 19:342\u2013353. \n                    https:\/\/doi.org\/10.1096\/fj.04-2175com","journal-title":"FASEB J"},{"key":"9778_CR10","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14763","author":"L Fattore","year":"2017","unstructured":"Fattore L et al. (2017) MicroRNAs in melanoma development and resistance to target therapy. Oncotarget. \n                    https:\/\/doi.org\/10.18632\/oncotarget.14763","journal-title":"Oncotarget"},{"key":"9778_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13177","author":"X Fu","year":"2017","unstructured":"Fu X et al (2017) MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K\/Akt pathway. Cancer Sci. \n                    https:\/\/doi.org\/10.1111\/cas.13177","journal-title":"Cancer Sci"},{"key":"9778_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2741\/4302","volume":"20","author":"R Hu","year":"2015","unstructured":"Hu R, Zhang Y, Yang X, Yan J, Sun Y, Chen Z, Jiang H (2015) Isoflurane attenuates LPS-induced acute lung injury by targeting miR-155-HIF1-alpha. Front Biosci 20:139\u2013156","journal-title":"Front Biosci"},{"key":"9778_CR13","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.celrep.2012.10.025","volume":"2","author":"TB Huffaker","year":"2012","unstructured":"Huffaker TB et al (2012) Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity. Cell Rep 2:1697\u20131709. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2012.10.025","journal-title":"Cell Rep"},{"key":"9778_CR14","first-page":"363","volume":"12","author":"BH Jiang","year":"2001","unstructured":"Jiang BH, Jiang G, Zheng JZ, Lu Z, Hunter T, Vogt PK (2001) Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 12:363\u2013369","journal-title":"Cell Growth Differ"},{"key":"9778_CR15","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1541-7786.MCR-13-0682","volume":"12","author":"S Joshi","year":"2014","unstructured":"Joshi S, Singh AR, Zulcic M, Durden DL (2014) A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1alpha and HIF2alpha stability and tumor growth, angiogenesis, and metastasis. Mol Cancer Res 12:1520\u20131531. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0682","journal-title":"Mol Cancer Res"},{"key":"9778_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.021","author":"M Kurowska-Stolarska","year":"2016","unstructured":"Kurowska-Stolarska M et al (2016) The role of microRNA-155\/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis. J Allerg Clin Immunol. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2016.09.021","journal-title":"J Allerg Clin Immunol"},{"key":"9778_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10735-017-9734-3","volume":"48","author":"Y Li","year":"2017","unstructured":"Li Y et al (2017) MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1. J Mol Histol 48:357\u2013366. \n                    https:\/\/doi.org\/10.1007\/s10735-017-9734-3","journal-title":"J Mol Histol"},{"key":"9778_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature03315","volume":"433","author":"LP Lim","year":"2005","unstructured":"Lim LP et al (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769\u2013773. \n                    https:\/\/doi.org\/10.1038\/nature03315","journal-title":"Nature"},{"key":"9778_CR19","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14392","author":"Q Lin","year":"2016","unstructured":"Lin Q, Ma L, Liu Z, Yang Z, Wang J, Liu J, Jiang G (2016) Targeting microRNAs: a new action mechanism of natural compounds. Oncotarget. \n                    https:\/\/doi.org\/10.18632\/oncotarget.14392","journal-title":"Oncotarget"},{"key":"9778_CR20","doi-asserted-by":"publisher","DOI":"10.1242\/bio.021774","author":"Y Lu","year":"2017","unstructured":"Lu Y, Ji N, Wei W, Sun W, Gong X, Wang X (2017) MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1alpha) in the tumor microenvironments. Biol Open. \n                    https:\/\/doi.org\/10.1242\/bio.021774","journal-title":"Biol Open"},{"key":"9778_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/wrr.12343","volume":"23","author":"EC Lynam","year":"2015","unstructured":"Lynam EC, Xie Y, Dawson R, McGovern J, Upton Z, Wang X (2015) Severe hypoxia and malnutrition collectively contribute to scar fibroblast inhibition and cell apoptosis. Wound Repair Regen 23:664\u2013671. \n                    https:\/\/doi.org\/10.1111\/wrr.12343","journal-title":"Wound Repair Regen"},{"key":"9778_CR22","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/1055-9965.EPI-12-0173","volume":"21","author":"S Mattiske","year":"2012","unstructured":"Mattiske S, Suetani RJ, Neilsen PM, Callen DF (2012) The oncogenic role of miR-155 in breast cancer. Cancer Epidemiol Biomark Prev 21:1236\u20131243. \n                    https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-0173","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"9778_CR23","doi-asserted-by":"publisher","first-page":"e0168572","DOI":"10.1371\/journal.pone.0168572","volume":"11","author":"OA Mesarwi","year":"2016","unstructured":"Mesarwi OA, Shin MK, Bevans-Fonti S, Schlesinger C, Shaw J, Polotsky VY (2016) Hepatocyte hypoxia inducible factor-1 mediates the development of liver fibrosis in a mouse model of nonalcoholic fatty liver disease. PLoS ONE 11:e0168572. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0168572","journal-title":"PLoS ONE"},{"key":"9778_CR24","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1038\/onc.2017.181","volume":"36","author":"P Mu","year":"2017","unstructured":"Mu P, Akashi T, Lu F, Kishida S, Kadomatsu K (2017) A novel nuclear complex of DRR1, F-actin and COMMD1 involved in NF-kappaB degradation and cell growth suppression in neuroblastoma. Oncogene 36:5745\u20135756. \n                    https:\/\/doi.org\/10.1038\/onc.2017.181","journal-title":"Oncogene"},{"key":"9778_CR25","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.4049\/jimmunol.1502240","volume":"196","author":"AA Qayum","year":"2016","unstructured":"Qayum AA et al (2016) IL-10-induced miR-155 targets SOCS1 to enhance IgE-mediated mast cell function. J Immunol 196:4457\u20134467. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1502240","journal-title":"J Immunol"},{"key":"9778_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1126\/science.1066315","volume":"294","author":"G Ruvkun","year":"2001","unstructured":"Ruvkun G (2001) Molecular biology. Glimpses of a tiny RNA world. Science 294:797\u2013799. \n                    https:\/\/doi.org\/10.1126\/science.1066315","journal-title":"Science"},{"key":"9778_CR27","first-page":"746","volume":"6","author":"H Shi","year":"2014","unstructured":"Shi H et al (2014) Ethanol extract of Portulaca oleracea L. reduced the carbon tetrachloride induced liver injury in mice involving enhancement of NF-kappaB activity. Am J Transl Res 6:746\u2013755","journal-title":"Am J Transl Res"},{"key":"9778_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10735-015-9645-0","volume":"47","author":"MA Sideek","year":"2016","unstructured":"Sideek MA, Teia A, Kopecki Z, Cowin AJ, Gibson MA (2016) Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar. J Mol Histol 47:35\u201345. \n                    https:\/\/doi.org\/10.1007\/s10735-015-9645-0","journal-title":"J Mol Histol"},{"key":"9778_CR29","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.2741\/4056","volume":"17","author":"J Wang","year":"2012","unstructured":"Wang J, Wu J (2012) Role of miR-155 in breast cancer. Front Biosci 17:2350\u20132355","journal-title":"Front Biosci"},{"key":"9778_CR30","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160571","author":"B Wang","year":"2017","unstructured":"Wang B, Yao K, Wise AF, Lau R, Shen HH, Tesch GH, Ricardo SD (2017) MicroRNA-378 reduces mesangial hypertrophy and kidney tubular fibrosis via MAPK signaling. Clin Sci. \n                    https:\/\/doi.org\/10.1042\/CS20160571","journal-title":"Clin Sci"},{"key":"9778_CR31","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1159\/000453218","volume":"40","author":"H Wu","year":"2016","unstructured":"Wu H et al (2016) MiR-155 is involved in renal ischemia-reperfusion injury via direct targeting of FoxO3a and regulating renal tubular cell pyroptosis. Cell Physiol Biochem 40:1692\u20131705. \n                    https:\/\/doi.org\/10.1159\/000453218","journal-title":"Cell Physiol Biochem"},{"key":"9778_CR32","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.3892\/mmr.2015.3327","volume":"11","author":"S Xie","year":"2015","unstructured":"Xie S, Chen H, Li F, Wang S, Guo J (2015) Hypoxia-induced microRNA-155 promotes fibrosis in proximal tubule cells. Mol Med Rep 11:4555\u20134560. \n                    https:\/\/doi.org\/10.3892\/mmr.2015.3327","journal-title":"Mol Med Rep"},{"key":"9778_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/dsu.12474","volume":"40","author":"J Zheng","year":"2014","unstructured":"Zheng J, Song F, Lu SL, Wang XQ (2014) Dynamic hypoxia in scar tissue during human hypertrophic scar progression. Dermatol Surg 40:511\u2013518. \n                    https:\/\/doi.org\/10.1111\/dsu.12474","journal-title":"Dermatol Surg"},{"key":"9778_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.biopha.2016.12.080","volume":"87","author":"B Zhou","year":"2017","unstructured":"Zhou B, Zhu H, Luo H, Gao S, Dai X, Li Y, Zuo X (2017) MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1. Biomed Pharmacother 87:412\u2013418. \n                    https:\/\/doi.org\/10.1016\/j.biopha.2016.12.080","journal-title":"Biomed Pharmacother"},{"key":"9778_CR35","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.neo.2017.06.002","volume":"19","author":"J Zhu","year":"2017","unstructured":"Zhu J et al (2017) NF-kappaB p65 overexpression promotes bladder cancer cell migration via FBW7-mediated degradation of RhoGDIalpha protein. Neoplasia 19:672\u2013683. \n                    https:\/\/doi.org\/10.1016\/j.neo.2017.06.002","journal-title":"Neoplasia"},{"key":"9778_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood-2012-08-449306","volume":"122","author":"E Zonari","year":"2013","unstructured":"Zonari E, Pucci F, Saini M, Mazzieri R, Politi LS, Gentner B, Naldini L (2013) A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. Blood 122:243\u2013252. \n                    https:\/\/doi.org\/10.1182\/blood-2012-08-449306","journal-title":"Blood"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10735-018-9778-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-018-9778-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-018-9778-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T14:45:55Z","timestamp":1558449955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10735-018-9778-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["9778"],"URL":"https:\/\/doi.org\/10.1007\/s10735-018-9778-z","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"29 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}